Novel pharmaceutical composition

Details Novel pharmaceutical composition Novel pharmaceutical composition

1989-02-28

1991-07-02

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514180, A61K 3156

Patent

active

050286005

ABSTRACT:
A composition for intravenous administration of 3-alpha-hydroxy-5-beta-pregnan-20-one (pregnanolone), comprising a stable oil-in-water emulsion, capable of being sterilized by autoclaving, of from 0.1 to 1.0 g of pregnanolone.

REFERENCES:
patent: 3163578 (1964-12-01), Bruckner et al.
patent: 3647829 (1972-03-01), Kruger
patent: 3900561 (1975-08-01), Davis et al.
patent: 3917830 (1975-11-01), Davis et al.
patent: 4168308 (1979-09-01), Wretlind et al.
patent: 4340594 (1982-07-01), Mizushima et al.

Affiliated with

Also associated with

Rating

Novel pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel pharmaceutical composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1247320